Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription products for oral cavity and pharynx; cough and cold; analgesics; nasal products; vitamin and mineral products; cerebral and peripheral circulation; vasoprotectives; health care products; and others. In addition, the company offers animal health products comprising antiparasitics, antimicrobials, and other products. Further, the company provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.
Metrics to compare | KRK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKRKPeersSector | |
---|---|---|---|---|
P/E Ratio | 14.4x | 17.1x | −0.5x | |
PEG Ratio | 0.53 | 0.17 | 0.00 | |
Price/Book | 2.5x | 2.0x | 2.6x | |
Price / LTM Sales | 3.0x | 1.8x | 3.2x | |
Upside (Analyst Target) | - | 11.5% | 40.5% | |
Fair Value Upside | Unlock | 29.3% | 4.4% | Unlock |